Clinical Trials Logo

Cognitive Dysfunction clinical trials

View clinical trials related to Cognitive Dysfunction.

Filter by:

NCT ID: NCT02773186 Completed - Clinical trials for Cognitive Dysfunction

Cerebral Oximetry With Near-infrared Spectroscopy and Negative Postoperative Behavioral Changes in Pediatric Surgery

Start date: December 2012
Phase: N/A
Study type: Observational

The main objective of the present study was to evaluate whether cerebral oxygen saturation is associated with an increase of NPOBC in pediatric patients undergoing major surgery.

NCT ID: NCT02768727 Completed - Clinical trials for Neurocognitive Dysfunction

A Test of Neural Inertia in Humans With Xenon

Start date: April 2016
Phase: Phase 2
Study type: Interventional

The dual objectives of this study are to determine if the phenomenon of neural inertia is present in humans and to determine whether the order of neurocognitive function is invariant among anesthetic agents. This study will enroll 24 healthy volunteers, ages 20-40 years, who will receive xenon gas (concentrations ranging from 0% to 60%) delivered via inhaled route through the ENHANCER 3000.

NCT ID: NCT02767388 Completed - Multiple Myeloma Clinical Trials

Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery

Chemobrain
Start date: September 1, 2016
Phase:
Study type: Observational

Broadly speaking, the goal of this study is to better understand the influence of chemotherapy treatment on the cognitive and neural mechanisms underlying human behavior. Extant literature lacks diversity in studied cancer populations and treatment protocols, and provides limited understanding of the cognitive abilities that are impaired by chemotherapy. To overcome these limitations, this study will employ a sophisticated battery of tests on an understudied cancer population. Eligible participants will either be patients diagnosed with hematological malignancy (HM) or demographically matched healthy control patients. After HM diagnosis and treatment protocols have been established, patients will be inducted into the longitudinal study comprised of three visits: 1) after diagnosis but prior to chemotherapy treatment (baseline), 2) after one treatment cycle (one month post-baseline), and 3) after three treatment cycles (three months post-baseline). Patients will undergo a test battery designed to measure specific behavioral and neural mechanisms of attention; tests will either be computer-based cognitive tasks or simulated driving tests that immerse patients into virtual driving scenarios. During each test, EEG will be concurrently measured through non-invasive scalp electrophysiology recordings; EEG recordings will reveal underlying neural mechanisms affected by chemotherapy. Additionally, neuropsychological tests of vision, attention, and memory will be administered, as well as questionnaires to evaluate health, mobility, and life space. Finally, blood samples will be collected to examine levels of circulating inflammation-specific proteins typically present in cancer patients. This study will allow us to better understand the mechanisms through which chemotherapy influences cognitive performance. Results from this study will influence the administration of chemotherapy treatments so that patients can continue to receive the highest medical care while maintaining optimal cognitive abilities and quality of life.

NCT ID: NCT02766062 Completed - Clinical trials for Postoperative Complications

Effects of Propofol and Sevoflurane on Early POCD in Elderly Patients With Metabolic Syndrome

Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate propofol versus sevoflurane anesthesia on the effects of early postoperative cognitive function in elderly patients with metabolic syndrome.

NCT ID: NCT02759965 Completed - Surgery Clinical Trials

Neuroinflammation and Cognitive Dysfunction After Orthopedic Surgery

Start date: September 1, 2014
Phase:
Study type: Observational

The primary hypothesis that orthopaedic surgery induces a neuroinflammatory response within 48 hours after elective hip or knee surgery and that there is an association between exaggerated CNS inflammatory response or impaired inflammatory resolution and postoperative cognitive dysfunction within one week and at three months postoperatively.

NCT ID: NCT02755246 Completed - Clinical trials for Subjective Cognitive Decline

Polyamine-enriched Diet in Healthy Older Adults With Subjective Cognitive Decline

preSmartAge
Start date: April 2016
Phase: Phase 2
Study type: Interventional

The overall objective of this study is to examine the effect of polyamine supplementation on cognitive performance of individuals with subjective cognitive decline.

NCT ID: NCT02748083 Completed - Schizophrenia Clinical Trials

Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in Schizophrenic

Start date: December 1, 2015
Phase: N/A
Study type: Interventional

This trial attempts to evaluate the effects of intensive transcranial direct-current stimulation (tDCS) on improving cognition in schizophrenia patients and changes in resting state brain network connectivity, especially increasing connectivity in the tasks related network, and increasing activation the DLPFC in a working memory task. Half of the participants will be randomized to tDCS group, while the other half will be randomized to receive sham tDCS.

NCT ID: NCT02739971 Completed - Type 2 Diabetes Clinical Trials

Dietary Reduction of AGEs to Prevent Cognitive Decline in Elderly Diabetics

Start date: June 2016
Phase: N/A
Study type: Interventional

Basic science and observational human studies suggest that high conentrations of circulating Advanced Glycation End-products (AGEs) may promote cognitive decline in older adults. The purpose of this pilot study is to test the methodology and feasibility of a dietary intervention to lower AGEs in elderly diabetics in order to lay the foundations for a future fully powered randomized clinical trial (RCT).To this end, the present study is focused on recruitment strategies, adherence to an innovative intervention in older adults and study methods. An exploratory aim will be the effect of the intervention on cognition and cerebral blood flow in order to obtain necessary data to estimate effect-size for a future fully-powered RCT.

NCT ID: NCT02738671 Completed - Obesity Clinical Trials

Relationship Between Diabetes and Cognitive Impairment Based on Olfactory Function Assessment and Functional MRI

Start date: January 2016
Phase:
Study type: Observational

The purpose of this study is to explore the relationship between diabetes and cognitive impairment by olfactory function assessment and functional MRI.

NCT ID: NCT02738034 Completed - Hypertension Clinical Trials

Cogmed Training Effect in Hypertensive Patients With Cognitive Impairment

Start date: August 2016
Phase: N/A
Study type: Interventional

Systemic arterial hypertension is a disease with high prevalence in several countries, including Brazil. Many studies have correlated hypertension with accelerated loss of cognitive function, especially executive functions. There is some evidence that working memory (WM) is compromised in these populations. However, some computerized training has been developed to rehabilitate the WM, and among them the investigators highlight the Cogmed. Thus, the aim of this study is to evaluate the effects of Cogmed training in the performance of WM and attention of hypertensive patients, as well as the impact of training in the structure and brain function.